Zacks Investment Management’s Atea Pharmaceuticals AVIR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-13,966	Closed	-$46.8K	–	661
2024 Q4	$46.8K	Sell	13,966 -9,974	-42%	-$33.4K	﹤0.01%	658
2024 Q3	$80.2K	Buy	+23,940	New	+$80.2K	﹤0.01%	666